Black Swan Analysis
Mid-Sized Business (10-100M TTM Revenue)
Black Swan Analysis is a boutique business analysis consultancy based in the UK.
Founded in 2007, the company provides a range of services to biotechs and university spin-outs, business development departments, CROs and investment companies. Our areas of expertise include forecasting excellence and patient segmentation which are supported by an array of proprietary tools such as comprehensive epidemiology and pricing databases.
Typical services include:
• Dynamic oncology flow modelling to value oncology assets at any stage of development (Onco-Strat)
• Regulator/ due- diligence- ready epidemiology data (Epiomic segmentation database)
• Prescription-only medicine ex-manufacturer pricing data for Europe (Rx Price Index)
• Custom disease area reports
• Competitive intelligence & market landscape assessments
• Product valuations / forecast models and market assessments
Our philosophy at Black Swan Analysis is to create a collaborative environment that enables us to provide an unparalleled level of satisfaction and quality to our clients.
Black Swan Analysis is part of Evaluate Ltd
|Evaluate Ltd 11-29 Fashion Street London, , 1E 6PX United Kingdom|
To request access, simply fill out the form below and we will contact you.